AGN - Allergan plc

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue15,940,70014,570,60012,688,1004,676,500
Cost of Revenue2,166,8001,808,1001,469,200983,500
Gross Profit13,773,90012,762,50011,218,9003,693,000
Operating Expenses
Research Development1,990,6002,581,2002,086,400583,800
Selling General and Administrative4,686,7004,277,7003,673,3001,832,900
Non Recurring----
Others----
Total Operating Expenses16,041,20015,137,40012,672,6005,336,000
Operating Income or Loss-100,500-566,80015,500-659,500
Income from Continuing Operations
Total Other Income/Expenses Net-10,285,900-2,265,200-4,563,000-2,338,700
Earnings Before Interest and Taxes-100,500-566,80015,500-659,500
Interest Expense-1,095,600-1,295,600-1,193,300-411,800
Income Before Tax-10,386,400-2,832,000-4,547,500-2,998,200
Income Tax Expense-6,670,400-1,897,000-1,605,900-513,600
Minority Interest16,0007,800-2,1004,400
Net Income From Continuing Ops-3,716,000-935,000-2,941,600-2,484,600
Non-recurring Events
Discontinued Operations-402,90015,914,5006,861,000854,100
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-4,125,50014,973,4003,915,200-1,630,500
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-4,403,90014,695,0003,683,200-1,630,500